Eradication Rates of Helicobacter Pylori Infection and Factors Influencing Treatment Outcomes: A single-Center Retrospective Cohort Study
Journal of Gastroenterology & Endoscopy · 30.06.2025 · 1-8
DOI: 10.61440/jge.2025v3.26 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Gastroenterology & Endoscopy, online erschienen am 30.06.2025. Verfasst von Ehab Alsayed Mohamed Soliman Eid.
Abstract (Originalsprache)
Background
Helicobacter pylori infection is one of the most common chronic bacterial infections worldwide and is a major cause of chronic gastritis, peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer. Although eradication therapy effectively reduces diseaserelated morbidity and mortality, its success has declined because of increasing antibiotic resistance, previous antibiotic exposure, and patient-related factors. Evaluating eradication rates and identifying predictors of treatment outcomes are therefore essential for optimizing therapeutic strategies in routine clinical practice.
Objective
To determine the eradication rate of Helicobacter pylori infection and identify demographic, lifestyle, clinical, diagnostic, and treatment-related factors associated with treatment outcomes among patients managed at a single healthcare centre.
Methods
A single-centre retrospective cohort study was conducted at Ahmed Maher Teaching Hospital, Cairo, Egypt, by reviewing medical records of adult patients treated for H. pylori infection between February 2023 and March 2025. A total of 525 eligible patients who received first-line standard triple therapy and underwent post-treatment confirmation testing were included. Data on demographic characteristics, lifestyle habits, comorbidities, diagnostic investigations, treatment characteristics, and eradication outcomes were collected. Associations between clinical variables and treatment outcomes were evaluated using chi-square tests and univariate logistic regression analysis.
Results
The mean age was 52.6 ± 12.7 years, and 50.5% of participants were female. The overall eradication rate was 84.2% (442/525), while treatment failure occurred in 15.8% of patients. Rapid urease testing (91.2%) and stool antigen testing (88.6%) were the most frequently used diagnostic methods. Significant predictors of eradication outcome included smoking (OR = 3.686, p = 0.002), family history of H. pylori infection (OR = 2.876, p = 0.031), diabetes mellitus (p < 0.001), and previous antibiotic exposure (OR = 5.486, p < 0.001). Univariate logistic regression identified age group, sex, family history, diabetes mellitus, and smoking habit as significant predictors of treatment outcome.
Conclusions
Standard triple therapy achieved satisfactory but suboptimal eradication of H. pylori infection in this cohort. Smoking, diabetes mellitus, family history, and previous antibiotic exposure were significant determinants of treatment outcomes. These findings support individualized treatment strategies, careful assessment of patient risk factors, and ongoing surveillance of eradication effectiveness to improve clinical outcomes and optimize H. pylori management.
Zitieren
APA
Eid, E. A. M. S. (2025). Eradication Rates of Helicobacter Pylori Infection and Factors Influencing Treatment Outcomes: A single-Center Retrospective Cohort Study. Journal of Gastroenterology & Endoscopy, 1-8. https://doi.org/10.61440/jge.2025v3.26
Vancouver
Eid EAMS. Eradication Rates of Helicobacter Pylori Infection and Factors Influencing Treatment Outcomes: A single-Center Retrospective Cohort Study. Journal of Gastroenterology & Endoscopy. 2025:1-8. doi:10.61440/jge.2025v3.26
BibTeX
@article{Eid2025,
author = {Eid, Ehab Alsayed Mohamed Soliman},
title = {Eradication Rates of Helicobacter Pylori Infection and Factors Influencing Treatment Outcomes: A single-Center Retrospective Cohort Study},
journal = {Journal of Gastroenterology & Endoscopy},
year = {2025},
pages = {1--8},
doi = {10.61440/jge.2025v3.26}
}
EUVIMED